Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Analysis of Profitability Ratios

Microsoft Excel

Profitability Ratios (Summary)

Baxter International Inc., profitability ratios

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Return on Sales
Gross profit margin 41.59% 48.93% 49.77% 51.45% 50.72%
Operating profit margin 4.50% 16.24% 17.48% 19.88% 21.20%
Net profit margin 9.71% 14.98% 13.19% 16.39% 16.01%
Return on Investment
Return on equity (ROE) 10.94% 30.75% 23.77% 33.53% 33.77%
Return on assets (ROA) 4.62% 9.63% 7.78% 11.41% 11.66%

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Baxter International Inc. gross profit margin ratio deteriorated from 2013 to 2014 and from 2014 to 2015.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Baxter International Inc. operating profit margin ratio deteriorated from 2013 to 2014 and from 2014 to 2015.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Baxter International Inc. net profit margin ratio improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Baxter International Inc. ROE improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.
ROA A profitability ratio calculated as net income divided by total assets. Baxter International Inc. ROA improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.

Gross Profit Margin

Baxter International Inc., gross profit margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Gross margin 4,146 8,157 7,595 7,301 7,046
Net sales 9,968 16,671 15,259 14,190 13,893
Profitability Ratio
Gross profit margin1 41.59% 48.93% 49.77% 51.45% 50.72%
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Gross profit margin = 100 × Gross margin ÷ Net sales
= 100 × 4,146 ÷ 9,968 = 41.59%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Baxter International Inc. gross profit margin ratio deteriorated from 2013 to 2014 and from 2014 to 2015.

Operating Profit Margin

Baxter International Inc., operating profit margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Operating income 449 2,707 2,668 2,821 2,946
Net sales 9,968 16,671 15,259 14,190 13,893
Profitability Ratio
Operating profit margin1 4.50% 16.24% 17.48% 19.88% 21.20%
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Operating profit margin = 100 × Operating income ÷ Net sales
= 100 × 449 ÷ 9,968 = 4.50%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Baxter International Inc. operating profit margin ratio deteriorated from 2013 to 2014 and from 2014 to 2015.

Net Profit Margin

Baxter International Inc., net profit margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to Baxter 968 2,497 2,012 2,326 2,224
Net sales 9,968 16,671 15,259 14,190 13,893
Profitability Ratio
Net profit margin1 9.71% 14.98% 13.19% 16.39% 16.01%
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Net profit margin = 100 × Net income attributable to Baxter ÷ Net sales
= 100 × 968 ÷ 9,968 = 9.71%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Baxter International Inc. net profit margin ratio improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.

Return on Equity (ROE)

Baxter International Inc., ROE calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to Baxter 968 2,497 2,012 2,326 2,224
Total Baxter shareholders’ equity 8,846 8,120 8,463 6,938 6,585
Profitability Ratio
ROE1 10.94% 30.75% 23.77% 33.53% 33.77%
Benchmarks
ROE, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
ROE = 100 × Net income attributable to Baxter ÷ Total Baxter shareholders’ equity
= 100 × 968 ÷ 8,846 = 10.94%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Baxter International Inc. ROE improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.

Return on Assets (ROA)

Baxter International Inc., ROA calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to Baxter 968 2,497 2,012 2,326 2,224
Total assets 20,975 25,917 25,869 20,390 19,073
Profitability Ratio
ROA1 4.62% 9.63% 7.78% 11.41% 11.66%
Benchmarks
ROA, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
ROA = 100 × Net income attributable to Baxter ÷ Total assets
= 100 × 968 ÷ 20,975 = 4.62%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Baxter International Inc. ROA improved from 2013 to 2014 but then deteriorated significantly from 2014 to 2015.